Lilly Brings Drug Development to the Classroom With New College Course Offering

INDIANAPOLIS, IN – Graduate students across the country with an interest in health care and medical research will soon have the opportunity to learn about a lesser-known area of patient care — the drug discovery and development process. Eli Lilly and Company (NYSE:LLY) has collaborated with 10 leaders from academic institutions to create an elective graduate level course, “Making Medicines: The Process of Drug Development.”  Lilly formally unveiled the eLearning course at the American Osteopathic Association scientific conference in Orlando, FL, October 17-21, and will launch its pilot program with academic partners beginning in 2016.

The online drug development course provides an interactive platform for students to explore the fundamental principles of drug development, learn about the regulatory environment that govern the biopharmaceutical industry, and identify the roles of key stakeholders, including physicians, who develop, investigate, and regulate biopharmaceutical products. The course includes seven chapters that contain various elements, such as expert videos from the perspective of the FDA and NIH, knowledge checks, case studies and competency tests.

“We identified a knowledge gap surrounding the biopharmaceutical industry and its drug discovery and development process,” says Yolanda Johnson-Moton, director–External Relations Medical Affairs, Lilly USA, “and set out to find a solution that would further education and awareness. Our unified focus is on creating better patient outcomes, and the healthcare providers of tomorrow are an integral part of the process.”

“The ‘Making Medicines: The Process of Drug Development’ course allows students to engage in a self-directed learning process to become familiar with drug discovery and development,” says Dr. Marc Kahn, senior associate dean, Tulane University School of Medicine. “Students will obtain useful knowledge in a self-paced setting and will apply that knowledge in a series of assessment exercises.  I plan to use this course as an elective for senior medical students who want to learn more about drug development, the FDA and the biopharmaceutical industry.”

The launch of the course comes shortly after the introduction of Lilly’s Medical Student Rotation Program, a four-week experiential learning program at their Indianapolis headquarters, where third- and fourth-year medical students familiarize themselves with the biopharmaceutical industry and its role in the practice of medicine through real-world projects and workshops. Future healthcare providers, who will be dependent on new medicines for their patients, will benefit from learning about the discovery and approval process.

“These student programs offer Lilly the opportunity to bring forth its longstanding focus on education and build collaborative relationships,” says Johnson-Moton. “The Making Medicines: The Process of Drug Development” course provides flexibility to fit within existing academic programs. Our goal is reach more students with an interest in medical research and help provide a balanced perspective on the process and rigor behind drug development.”

To learn more, visit: www.making-medicines.com/information

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com.

Featured

  • Springfield Breaks Ground on $53.7M Pipkin Middle School Rebuild

    Construction is underway on a new, state-of-the-art Pipkin Middle School in Springfield, Mo., a major step in Springfield Public Schools’ (SPS) long-term facility improvement plan, according to local news. The $53.7-million project officially broke ground in early June, following years of planning and community input aimed at modernizing aging infrastructure and addressing student capacity concerns.

  • ProTeam Launches GoFit 6 HEPA Backpack Vacuum

    Technology leader Emerson recently introduced the new ProTeam GoFit 6 HEPA backpack vacuum, according to a news release. The vacuum was designed to capture 99.97% of particulates down to 0.3 microns—including atmospheric hazards like lead dust, mold spores, and other particulates—through an advanced filtration system.

  • California High School Starts Construction on New CTE Building

    Analy High School, part of the West Sonoma County Union High School District (WSCUHSD) in Sebastopol, Calif., recently broke ground on a new Career Technical Education (CTE) Building, according to a news release. The 15,000-square-foot facility will offer specialized facilities for students in engineering, welding, culinary arts, agricultural sciences, and design thinking.

  • modern college building with circuit and brain motifs

    Anthropic Introduces Claude for Education

    Anthropic has launched a version of its Claude AI assistant tailored for higher education institutions. Claude for Education "gives academic institutions secure, reliable AI access for their entire community," the company said, to enable colleges and universities to develop and implement AI-enabled approaches across teaching, learning, and administration.

Digital Edition